Statistics from Altmetric.com
The correct answer is methylprednisolone. Echocardiography demonstrated an apical mass with obliteration of the left ventricular apex and extensive apical late gadolinium enhancement confirmed on CMR. Left ventricular function was preserved with no evidence of thrombus formation (see online supplementary movies 1 and 2). In combination with the clinical presentation, these findings were suggestive of acute eosinophilic myocarditis with an apical eosinophilic infiltrate.1 Myeloperoxidase immunofluorescence pointed towards a unifying diagnosis of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). This acute presentation differs from the ‘classical’ subacute appearance on CMR where there is usually ventricular thinning with superimposed endocardial thrombus. The first-line treatment is immunosuppression with methylprednisolone.2⇑
Echocardiography video loop in modified four chamber view.
Cine magnetic resonance sequence in four chamber view.
Hypereosinophilic syndrome with cardiac involvement has been characterised in three stages: an acute necrotic stage with eosinophilic infiltration, a subacute phase with thrombus formation overlying the disrupted endocardium and chronic fibrotic progression to a restrictive cardiomyopathy. In the acute stage, medical therapy for chronic systolic heart failure is not indicated in the context of preserved left ventricular function. Antibiotics are not indicated in the absence of bacterial infection. Endocardiectomy with preservation of the atrioventricular valve apparatus is advocated for advanced endomyocardial fibrosis to reduce ventricular filling pressures; however, it is not warranted during the acute phase.3 Primary ICD therapy is not indicated in the absence of recurrent ventricular tachyarrhythmias.4
The patient was treated with methylprednisolone and cyclophosphamide. After 12 months of treatment, she had fully recovered with resolution of her peripheral eosinophilia and cardiac findings. Eosinophilic myocarditis has a high mortality rate, but early identification and treatment can lead to a regression of fulminant myocardial necrosis.
Contributors AJM and MRD wrote the manuscript and prepared the images. PDO was involved in the clinical care of the patient.
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.